NEW YORK (GenomeWeb) – Mawi DNA Technologies has signed a distribution agreement with Alliance Global (AGBL) to distribute Mawi's iSWAB biosampling technologies to the Middle East, Africa, and parts of Central and South Asia.
Under the deal, AGBL will be an authorized agent and distributor for Mawi products in Kuwait, Bahrain, Qatar, Yemen, Oman, UAE, Iran, Jordan, Syria, Lebanon, Iraq, Palestine, Africa, Turkey, Pakistan, Sri Lanka, Afghanistan, Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, Turkmenistan, Azerbaijan, Thailand, Philippines, Vietnam, the Maldives, Mongolia, Singapore, Indonesia, Brunei, Myanmar, and Malaysia.
Hayward, California-based Mawi was founded in 2013 and markets the iSWAB technology for biosample collection. The company's flagship product, iSWAB-DNA, can be used for animals and all human population segments, producing a high DNA yield with low bacterial DNA content.
"The collaboration with Mawi DNA Technologies to provide sample collection kits for all applications to our end users complements the AGBL Genomics product range and allows us to support them by offering a complete solution in the markets we serve," Althea Fernandes, product manager for genomics at Alliance Global Group, said in a statement.
Bassam El-Fahmawi, president and chief technology officer of Mawi DNA Technologies, noted in a statement that the deal "facilitates Mawi's access to new markets and ... strengthens our presence in others" and is "a critical step in Mawi DNA's growth in the international marketplace."